| Net Cash Provided by (Used in) Operating Activities |
1.91M |
USD |
+18.9% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
-45.6K |
USD |
+71% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
-551K |
USD |
+35.3% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
200K |
shares |
0% |
Q4 2024 |
FY 2024 |
| Common Stock, Shares, Issued |
185K |
shares |
0% |
Q4 2024 |
FY 2024 |
| Common Stock, Par or Stated Value Per Share |
0.5 |
USD/shares |
0% |
Q4 2024 |
FY 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
1.31M |
USD |
+120% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
3.92M |
USD |
-24.8% |
Q4 2024 |
FY 2024 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
11.8K |
USD |
-9.17% |
Q1 2025 |
Q1 2025 |
| Depreciation |
0 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
350K |
USD |
-51.8% |
Q2 2024 |
Q2 2024 |
| Deferred Income Tax Expense (Benefit) |
488K |
USD |
+86.3% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
173K |
USD |
|
Q4 2024 |
FY 2024 |
| Current Income Tax Expense (Benefit) |
157K |
USD |
-0.68% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
2.67M |
USD |
+23.8% |
Q4 2024 |
FY 2024 |
| Interest Expense |
16.1K |
USD |
-3.81% |
Q1 2025 |
Q1 2025 |